NObreath Catalogue (2nd Gen)
12Pages

{{requestButtons}}

Catalog excerpts

NObreath Catalogue (2nd Gen) - 1

Measure breath nitric oxide for airway inflammation with the NObreath® FeNO monitor Aids in the diagnosis and management of asthma, one breath at a time. 1 www.bedfont.com on +44(0)1622 851122 or email ask@bedfont.com Made in UK

Open the catalog to page 1
NObreath Catalogue (2nd Gen) - 2

For more information on this product call us now

Open the catalog to page 2
NObreath Catalogue (2nd Gen) - 3

Contents Fractional Exhaled Nitric Oxide (FeNO) Benefits of performing FeNO tests NObreath® features 6 Measuring FeNO with NObreath® Technical specification NObreath® Forum Interpretation chart

Open the catalog to page 3
NObreath Catalogue (2nd Gen) - 4

Fractional Exhaled Nitric Oxide (FeNO) Fractional exhaled nitric oxide is a good marker for eosinophilic airway inflammation, and is considered to be a good indicator of corticosteroid response1. The production of nitric oxide is often found to be higher in inflammatory conditions such as asthma and therefore FeNO monitoring can be used for the detection and management of such conditions2, but also to differentiate between COPD, ACOS and other interstitial lung diseases that are not assessed by other means, such as lung function3. Nitric oxide measurement is not intended as a stand-alone...

Open the catalog to page 4
NObreath Catalogue (2nd Gen) - 6

NObreath® features An ergonomic design, fully-portable and incorporated with SteriTouch® technology for optimum infection control. *Subject to correct use, maintenance and service. Tested up to 29,000 tests. 6 For more information on this product call us now

Open the catalog to page 6
NObreath Catalogue (2nd Gen) - 7

Measuring FeNO with NObreath® Consumables NObreath® Mouthpiece The NObreath® uses a single-patient use mouthpiece, which contains an integrated infection control filter that removes and traps >99% of airborne bacteria and >98% of viruses8.

Open the catalog to page 7
NObreath Catalogue (2nd Gen) - 8

Technical specification Concentration range Full colour touchscreen Detection principle Electrochemical sensor ±5ppb of measured value ≤ 50ppb ±10% of measured value > 50ppb ±5ppb of measured value ≤ 50ppb ±10% of measured value > 50ppb NObreath® monitor 1 x main rechargeable Li-ion battery- Approx. 100 uses on fully charged battery 2 x Li-ion coin cell battery- Approx. 5 years Input: 5V, 0.5A NObreath® Dock Mains powered Input: 5V, 0.5A Output: 5V, 0.5A T90 response time Temperature Operating/storage/transport pressure Sensor operating life 5 years (Subject to servicing) Sensor sensitivity...

Open the catalog to page 8
NObreath Catalogue (2nd Gen) - 9

FeNOchart™ FeNOchart™ is free patient management software available with every NObreath®. FeNOchart™ enables you to track patients’ progress, view live readings, download results plus much more. FREE FeNOchart™ patient management software. NObreath® Forum Purchasing a NObreath® entitles you to free membership of the NObreath® forum. The NObreath® forum is an international, invitation-only platform where professionals using the Bedfont® NObreath® FeNO monitor can communicate, share experiences and knowledge, and ask for other professional opinions. There is no cost or obligation to...

Open the catalog to page 9
NObreath Catalogue (2nd Gen) - 10

Using FeNO to assist diagnosis Measuring airway inflammation with NObreath® can help monitor the effectiveness Aid in diagnosis using the NObreath® FeNO monitor FeNO (ppb) Levels Symptomatic (chronic cough and/or wheeze and/or shortness of breath during past 6 wk) LOW <25ppb (<20ppb in children) Eosinophilic airway inflammation unlikely Alternative diagnosis INTERMEDIATE 25-50ppb (20-35ppb in children) Be cautious Evaluate clinical context HIGH >50ppb (>35ppb in children) or rise in FeNO of >40% from previously stable levels Eosinophilic airway inflammation present Likely to benefit from...

Open the catalog to page 10
NObreath Catalogue (2nd Gen) - 11

of medication and can be used to predict the risk of Asthma attacks*. Monitoring (in patients with diagnosed asthma) using the NObreath® FeNO monitor FeNO (ppb) Levels LOW <25ppb (<20ppb in children) Possible alternative diagnosis. Symptomatic (chronic cough Unlikely to benefit from and/or wheeze increase in ICS and/or shortness of breath during past 6 wk) Adequate ICS dose Symptoms Absent Good adherence HIGH >50ppb (>35ppb in children) or rise in FeNO of >40% from previously stable levels Persistent allergen exposure Persistent allergen exposure Poor adherence or inhaler technique Poor...

Open the catalog to page 11
NObreath Catalogue (2nd Gen) - 12

Contact Bedfont® or one of our worldwide NObreath® distributors for a free demonstration. www.bedfont.com Tel:+44 (0)1622 851122 Email: ask@bedfont.com Our family, innovating health, for yours. Visit www.bedfont.com/resources to view this document in other languages. Bedfont® Scientific Ltd. Station Road, Harrietsham, Maidstone, Kent, ME17 1JA England Tel: +44 (0)1622 851122 Fax: +44 (0)1622 854860 Email: ask@bedfont.com Web: www.bedfont.com Stephen Rowe Cristimar E4-1 Ave Juan Carlos I Los Cristianos, Arona, 38650 Santa Cruz de Tenerife, Spain © Bedfont® Scientific Limited 2022 12 Issue 8...

Open the catalog to page 12

All Bedfont Scientific catalogs and technical brochures

Archived catalogs